June 19th, 2009
Podcast 46: Does Genetic Testing for Clotting Mutations Matter? An interview with Jodi Segal of Johns Hopkins
Podcast: Play in new window | Download
Subscribe: RSS
You’d think that a widely-ordered test would play a part in management and outcome, but two clotting mutations seem exceptions to that rule. Although often requested, the FDA-approved tests for Factor V Leiden and G20210A mutations don’t seem to figure greatly in case management of venous thromboembolism, at least according to the published literature. Dr. Jodi Segal and her team published a meta-analysis in JAMA this week, and she’s here to discuss the results.
This week’s links:
News–
- CDC Counsels Infection-Control Vigilance to Prevent H1N1 in Health Workers
- Zicam Nasal Cold Remedies Linked to Loss of Sense of Smell
- Stents Not Associated with Improved Function in Renal Artery Stenosis
- Leukotriene Modifiers for Asthma Associated with Neuropsychiatric Adverse Events
Interview links–
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
